SFM
PDLI
Systematic Financial Management’s PDL BioPharma, Inc. PDLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-120,410
| Closed | -$340K | – | 578 |
|
|
2020
Q1 | $340K | Sell |
120,410
-32,610
| -21% | -$92.1K | 0.02% | 275 |
|
|
2019
Q4 | $497K | Sell |
153,020
-97,915
| -39% | -$318K | 0.02% | 415 |
|
|
2019
Q3 | $542K | Sell |
250,935
-22,490
| -8% | -$48.6K | 0.02% | 347 |
|
|
2019
Q2 | $859K | Sell |
273,425
-84,555
| -24% | -$266K | 0.03% | 422 |
|
|
2019
Q1 | $1.33M | Sell |
357,980
-59,220
| -14% | -$220K | 0.05% | 319 |
|
|
2018
Q4 | $1.21M | Sell |
417,200
-186,260
| -31% | -$540K | 0.04% | 310 |
|
|
2018
Q3 | $1.59M | Buy |
603,460
+107,610
| +22% | +$283K | 0.04% | 304 |
|
|
2018
Q2 | $1.16M | Sell |
495,850
-71,945
| -13% | -$168K | 0.03% | 527 |
|
|
2018
Q1 | $1.67M | Sell |
567,795
-32,730
| -5% | -$96.2K | 0.04% | 289 |
|
|
2017
Q4 | $1.65M | Buy |
600,525
+101,695
| +20% | +$279K | 0.03% | 315 |
|
|
2017
Q3 | $1.69M | Sell |
498,830
-215,810
| -30% | -$732K | 0.03% | 312 |
|
|
2017
Q2 | $1.77M | Buy |
714,640
+2,585
| +0.4% | +$6.38K | 0.03% | 401 |
|
|
2017
Q1 | $1.62M | Sell |
712,055
-1,030
| -0.1% | -$2.34K | 0.03% | 482 |
|
|
2016
Q4 | $1.51M | Buy |
713,085
+176,360
| +33% | +$374K | 0.02% | 547 |
|
|
2016
Q3 | $1.8M | Sell |
536,725
-54,770
| -9% | -$183K | 0.03% | 387 |
|
|
2016
Q2 | $1.86M | Buy |
591,495
+119,545
| +25% | +$375K | 0.03% | 358 |
|
|
2016
Q1 | $1.57M | Buy |
471,950
+1,450
| +0.3% | +$4.83K | 0.02% | 460 |
|
|
2015
Q4 | $1.67M | Buy |
470,500
+64,580
| +16% | +$229K | 0.02% | 444 |
|
|
2015
Q3 | $2.04M | Buy |
405,920
+25,735
| +7% | +$129K | 0.02% | 460 |
|
|
2015
Q2 | $2.44M | Buy |
+380,185
| New | +$2.44M | 0.02% | 507 |
|
|
2014
Q1 | – | Sell |
-216,172
| Closed | -$1.82M | – | 784 |
|
|
2013
Q4 | $1.82M | Buy |
216,172
+36,760
| +20% | +$310K | 0.01% | 535 |
|
|
2013
Q3 | $1.43M | Sell |
179,412
-6,000
| -3% | -$47.8K | 0.01% | 548 |
|
|
2013
Q2 | $1.43M | Buy |
+185,412
| New | +$1.43M | 0.01% | 499 |
|